Epinephrine administration for severe adverse reactions to contrast agents.
Samett
E J
EJ
Espinosa
G A
GA
D000707:Anaphylaxis / Q000139:chemically induced / Q000188:drug therapy*; D003287:Contrast Media / Q000009:adverse effects*; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use*; D005682:Gadolinium / Q000009:adverse effects*; D006571:Heterocyclic Compounds / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D009942:Organometallic Compounds / Q000009:adverse effects*
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium; D004837:Epinephrine